Ulf Rosén

Ulf Rosén General Information

Biography

Mr. Ulf Rosén serves as Founding Investor & Board Member at Cavix. He was a Co-Founder & served as Chief Executive Officer at Lobsor Pharmaceuticals. He has more than 35 years of proven experience in the pharmaceutical and medical technology industry including more than 20 years at startup and early-stage companies as investor, CEO and Board Member/Chairman. During his career, he has been directly involved in a number of strategic investments and M&A activities. He was instrumental in pioneering the development of levodopa-carbidopa intestinal gel, which was commercialized in the EU member states as Duodopa® Such success led to its acquisition by Solvay Phamaceuticals and Abbott/AbbVie where Duodopa® was subsequently approved in the United States. He was also Co-founder and CEO of Lobsor Pharmaceuticals, which was acquired by STADA/Britannia in September 2020. Previously, he held senior management positions in larger organizations including as CEO for Pharmacia & Upjohn Norway as well as Executive Vice President of Fresenius Kabi Global Nutrition Division. He is a co-founder of, and currently serves as Chairman of the Board, of Intrance Medical Systems, a US-based company focused on the advancement of a next-generation therapy for advanced Parkinson's disease. He also currently serves as independent board member of Acarix AB (listed at Nasdaq First North), Tridentify AB, Multi4 Medical AB, is founder of Ponscasa Holding AB and vice chairman of Almtuna IS icehockey club.